Bioter S.A. (BIOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bioter S.A. (BIOT) has a cash flow conversion efficiency ratio of 0.023x as of December 2022. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.46 Million ≈ $-2.88 Million USD) by net assets (€-106.17 Million ≈ $-124.12 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review BIOT financial flexibility score to assess the company's free cash flow relative to its total liabilities.
Bioter S.A. - Cash Flow Conversion Efficiency Trend (2014–2022)
This chart illustrates how Bioter S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Bioter S.A. market cap and net worth for the company's overall valuation and market capitalisation.
Bioter S.A. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioter S.A. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Property Franchise Group PLC
LSE:TPFG
|
0.089x |
|
Pool Safe Inc
V:POOL
|
-3.557x |
|
Aurora Investment Trust plc
LSE:ARR
|
0.004x |
|
Alvo Minerals Ltd
AU:ALV
|
-2.176x |
|
Absolicon Solar Collector AB Series B
ST:ABSL-B
|
-0.041x |
|
Odd Burger Corp
V:ODD
|
0.012x |
|
H&T Group plc
LSE:HAT
|
0.033x |
|
Sherpa II Holdings Corp
V:SHRP
|
-0.016x |
Annual Cash Flow Conversion Efficiency for Bioter S.A. (2014–2022)
The table below shows the annual cash flow conversion efficiency of Bioter S.A. from 2014 to 2022. View BIOT stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2022-12-31 | €-106.17 Million ≈ $-124.12 Million |
€-9.46 Million ≈ $-11.06 Million |
0.089x | +34.82% |
| 2021-12-31 | €-96.49 Million ≈ $-112.81 Million |
€-6.38 Million ≈ $-7.45 Million |
0.066x | -36.34% |
| 2020-12-31 | €-87.69 Million ≈ $-102.52 Million |
€-9.10 Million ≈ $-10.64 Million |
0.104x | +51.53% |
| 2019-12-31 | €-93.64 Million ≈ $-109.48 Million |
€-6.41 Million ≈ $-7.50 Million |
0.068x | -17.40% |
| 2018-12-31 | €-85.02 Million ≈ $-99.39 Million |
€-7.05 Million ≈ $-8.24 Million |
0.083x | -57.38% |
| 2017-12-31 | €-71.39 Million ≈ $-83.47 Million |
€-13.89 Million ≈ $-16.24 Million |
0.195x | +47.08% |
| 2016-12-31 | €-54.16 Million ≈ $-63.32 Million |
€-7.16 Million ≈ $-8.38 Million |
0.132x | -46.53% |
| 2015-12-31 | €-35.44 Million ≈ $-41.43 Million |
€-8.77 Million ≈ $-10.25 Million |
0.247x | -34.62% |
| 2014-12-31 | €-25.33 Million ≈ $-29.61 Million |
€-9.58 Million ≈ $-11.20 Million |
0.378x | -- |
About Bioter S.A.
Bioter S.A. operates as a technical construction company in Greece and internationally. The company is involved in the execution of various projects, such as roads, ports, industrial-energy, electromechanical-communications, airports, war industries factories, etc., as well as private projects, such as offices, banks, bus stations, etc. The company was founded in 1961 and is based in Athens, Gree… Read more